HashKey Capital unveiled a BTC-denominated Bitcoin Hashrate Fund on July 2, 2026, using BITMAIN as an independent ...

In a statement published on X, the team behind the Sei-based decentralized exchange said declining revenue had made it ...

Introduction Choosing Bitcoin mining hardware can feel confusing, especially for beginners. New models are released regularly ...

This document is intended for journalists, civil society or members of the public who are looking for a non-exhaustive, ...

KUCHING: Up to 4,000 runners will converge here for Interhash 2028 after the state capital won the bid to host one of the ...

When the keyboard was first designed, the intention was to keep every key in the right position as per its estimated usage. However, that was in the typewriter era. The common uses have changed with ...

If you can’t find your BitLocker recovery key, this post will help you. BitLocker is a volume encryption feature in Windows that lets you encrypt an entire volume to protect your data. It provides a ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...